UPDATE - INVESTOR ALERT: Levi & Korsinsky, LLP Launches an Investigation of the Board of Directors of Hospira Inc. In Connect...
09 Fevereiro 2015 - 2:53PM
Business Wire
Levi & Korsinsky is commencing an investigation into the
Board of Directors of Hospira Inc. (“Hospira” or “the Company”)
(NYSE:HSP) in connection with possible breaches of fiduciary duty
and other violations of state law in connection with the sale of
the Company to Pfizer.
Click here to learn more about the investigation:
http://zlk.9nl.com/hospira.
Under the terms of the transaction, Hospira shareholders will
receive $90 in cash for each share of Hospira stock they own. The
investigation concerns whether the Board of Hospira breached their
fiduciary duties to stockholders by failing to adequately shop the
Company before agreeing to enter into this transaction, and whether
Pfizer is underpaying for Hospira shares.
If you own Hospira common stock and wish to obtain additional
information, please contact Joseph E. Levi, Esq. either via email
at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free:
(877) 363-5972, or visit http://zlk.9nl.com/hospira.
Levi & Korsinsky is a national firm with offices in New
York, New Jersey, Connecticut and Washington D.C. The firm’s
attorneys have extensive expertise in prosecuting securities
litigation involving financial fraud, representing investors
throughout the nation in securities and shareholder lawsuits. For
more information, please feel free to contact any of the attorneys
listed below. Attorney advertising. Prior results do not guarantee
similar outcomes.
Levi & Korsinsky, LLPJoseph Levi, Esq.Eduard Korsinsky,
Esq.212-363-7500Toll Free: 877-363-5972Fax:
866-367-6510www.zlk.com
Hospira (NYSE:HSP)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Hospira (NYSE:HSP)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024
Notícias em tempo-real sobre da New York Stock Exchange bolsa de valores: 0 artigos recentes
Mais Notícias de Hospira